Many of the largest US companies have undertaken to invest trillions in the United States since President Donald Trump started his second term – including six names in our portfolio. These steps aim to organize companies with the president's vision for a new global trade regulation in order to regain the jobs from overseas and to deal with what he sees as decades of unfair tariff obstacles abroad. We have kept an eye on these promises and new companies are added to the list every day. Here you will find an overview of six portfolio names in alphabetical order, which have committed themselves to major investments in the United States and how you can see further developing in the changing trade landscape. Abbott Laboratories: Abbott has promised 500 million US dollars last month for the modernization of manufacturing skills in plants in Illinois and Texas and to expand research and development (F&E). Around 200 new jobs are expected in Illinois and 100 in Texas, said a company spokesman Bloomberg. This is part of Abbott's short -term plan to reduce the tariff effects, which management appreciates to “a few hundred million dollars”. In a volatile year for stocks, Abbott has increased more than 19% to date. It is the second best performance of the club in 2025. Apple: As part of its obligation to invest $ 500 billion in the USA over four years, Apple said in February that it would open a new factory for artificial intelligence servers in Houston, Texas. The 250,000 square meter complex is to be opened next year. Apple also plans to bring around 20,000 new settings across the country on board for over four years. Recently, CEO Tim Cook said that teams and institutions will be expanded in countries such as Michigan, California and Texas last week. Assuming the current tariff, Cook estimated the additional costs of 900 million US dollars in the June Quartal, but would not endanger any assumption. Apple has declined almost 21% to date. It is our worst value that is bad in 2025. In addition to the club name Nvidia, Apple has the most to lose if the tensions of the US China do not improve. Bristol Myers Squibb: The drug manufacturer will invest 40 billion US dollars in the United States over the next five years, which will expand its F&E and the production of footprint in the country. Christopher Boerner, CEO of Bristol Myers, said on Monday that the funds in relation to research and development, technology and household production will pass. “With this investment plan, we will strengthen our presence across the country, increase radiopharmaceutical production and invest in artificial intelligence and machine learning to help us significantly increase the pace of innovation,” wrote Boerner. In the past month, Bristol Myers hiked the instructions for the publication of income and constitutes existing tariffs for US products that were imported in China. The share has fallen by more than 16% to this day. It is our two -bad test in 2025. Eaton: The Global Power Management Company announced plans in February to add a new transformer production in Jonesville, South Carolina. The company there will support data centers, the modernization of the grids as well as electrification and industrialization. Eaton will spend $ 340 million to increase the US production of its three-phase transformers. Eaton has invested more than 1 billion US dollars in the production of electrical solutions in North America since 2023. The incoming CEO Paulo Ruiz said about the winning call of the past week that the company wants to deal with the tariffs by adapting costs, supply chains and prices as required. Eli Lilly: Lilly wants to expand his domestic presence with four new pharmaceutical production locations. This investment of 27 billion US dollars announced in February raises the total capital expansion obligations of ELI Lilly in the United States to over 50 billion US dollars since 2020. Lilly expects the four new locations to bring more than 3,000 jobs, including engineers, scientists, operating staff and laboratory technicians. Like Bristol Myers, Lilly is still waiting to hear whether Trump will put industry -specific tariffs on pharmaceutical. The president and the administrative officers have indicated that they are coming. Lilly Management expects the announced tariffs “Financial effects only have limited effects, which we have transferred in our 2025 guidelines” about sales between 58 and 61 billion US dollars. Lilly's shares have fallen about 1.5% year to date. You would have been much higher if she did not start the news about a partnership between CVSHEALTH and competition from Novo Nordisk in weight loss medication last week. NVIDIA: With partnerships with Taiwan Semiconductor Manufacturing, Foxconn, Wistron and others, Nvidia promised to produce an AI infrastructure worth up to 500 billion US dollars in the United States over four years in the USA. The company's production of some Blackwell chips began in TSMC's work in Phoenix. Nvidia also builds supercomputer with Foxconn in Houston and Wistron in Dallas. Production is expected in both facilities in the next 12 to 15 months. The shares of Nvidia, which only show the result on May 28, have so far decreased by 12%. On Wednesday, the Nvidia investors breathed relief after the Trump government scraped the implementation of a controversial rule for AI chip exports from the bid era. Last month, however, Trump tightened another bid-chip export rule and said that slower, China chips need a license. As a result, Nvidia announced on April 15 that it would book an inventory fee of 5.5 billion US dollars. (Jim Cramers Charitible Trust is long AAPL, Abbot, BMY, LLY, ETN, NVDA. Further information can be found here for a full list of shares.) As a subscriber of the CNBC Investing Club with Jim Cramer, you will receive a trade war before Jim Handel. Jim waits for 45 minutes after he has sent a trade warning before bought or selling a share in the portfolio of his non -profit trust. When Jim spoke about a share on CNBC television, he waits 72 hours after the output of the trade war before he executed the trade. The above -mentioned investment club information is subject to our general terms and conditions and data protection guidelines together with our disclaimer. There is no trust or strategy or is created due to its receipt of information provided in connection with the Investing Club. It is not guaranteed to be a specific result or profit.
People will pass the Apple Store in the Fifth Avenue in New York City on May 1, 2025.
Kylie Cooper | Reuters
Many of the largest US companies have undertaken to invest trillions in the United States since President Donald Trump started his second term – including six names in our portfolio.
